LISA/MIST: Complex clinical problems almost never have easy solutions

Daniele De Luca, Shivani Shankar-Aguilera, Eduardo Bancalari

Research output: Contribution to journalArticlepeer-review

Abstract

Over the last 10 years, new techniques to administer surfactant have been promoted, based on their presumed lesser invasiveness and they have been generally called LISA (less invasive surfactant administration). We believe that the clinical potential of LISA techniques is currently overestimated. LISA lacks biological and pathophysiological background justifying its potential benefits. Moreover, LISA has been investigated in clinical trials without previous translational data and these trials are affected by significant flaws. The available data from these trials only allow to conclude that LISA is better than prolonged, unrestricted invasive ventilation with loosely described parameters, a mode of respiratory support that should be anyway avoided in preterm infants. We urge the conduction of high-quality studies to understand how to choose and titrate analgesia/sedation and optimize surfactant administration in preterm neonates. We offer a comprehensive, evidence-based review of the clinical data on LISA, their biases and the lack of physiopathology background.

Original languageEnglish (US)
Article number101230
JournalSeminars in Fetal and Neonatal Medicine
Volume26
Issue number2
DOIs
StatePublished - Apr 2021

Keywords

  • INSURE
  • Preterm neonates
  • Respiratory distress
  • Surfactant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'LISA/MIST: Complex clinical problems almost never have easy solutions'. Together they form a unique fingerprint.

Cite this